Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monofer vs Venofer in CKD iron deficiency anemia (China, Phase III)
CTR20150647Phase 3Completed
- Sponsor
- Pharmacosmos
- Start
- Oct 2015
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of ferric derisomaltose in iron deficiency anemia (IDA), chronic kidney disease (CKD), sponsored by Pharmacosmos. Started Oct 2015; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)chronic kidney disease (CKD)
Beyond the preview
Go deeper on CTR20150647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150647.